SW
Stacie Weninger
Executive Director at F-Prime Biomedical Research Initiative
Waban, Massachusetts
Overview
Stacie Weninger is the Executive Director at F-Prime Biomedical Research Initiative in Waban, Massachusetts. She has a Ph.D. from Harvard University and has held key roles at Fidelity, Harvard University, and Cell Press, with notable achievements including leading investments in companies like Engrail Therapeutics and Denali Therapeutics.
Work Experience
Executive Director
2009 - Current
President, Alzforum
F-Prime Capital is a venture capital firm investing in healthcare and technology.
Science Program Director
2005 - 2009
Fidelity is a privately-owned investment manager focusing on a diverse set of customers.
Raised $152,825,000.00.
Senior Analyst and Project Manager, Task Force on Women in Science
2005 - 2005
Senior Scientist, Neuron
2001 - 2005
CellPress is a print media company that publishes biomedical research and reviews.